Cite
Bove T, Matteazzi A, Belletti A, et al. Beneficial impact of levosimendan in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials. Heart Lung Vessel. 2015;7(1):35-46
Bove, T., Matteazzi, A., Belletti, A., Paternoster, G., Saleh, O., Taddeo, D., Dossi, R., Greco, T., Bradic, N., Husedzinovic, I., Nigro Neto, C., Lomivorotov, V. V., & Calabrò, M. G. (2015). Beneficial impact of levosimendan in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials. Heart, lung and vessels, 7(1), 35-46.
Bove, Tiziana, et al. "Beneficial impact of levosimendan in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials." Heart, lung and vessels vol. 7,1 (2015): 35-46.
Bove T, Matteazzi A, Belletti A, Paternoster G, Saleh O, Taddeo D, Dossi R, Greco T, Bradic N, Husedzinovic I, Nigro Neto C, Lomivorotov VV, Calabrò MG. Beneficial impact of levosimendan in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials. Heart Lung Vessel. 2015;7(1):35-46. PMID: 25861589; PMCID: PMC4381821.
Copy
Download .nbib